Stock Events

Stock Events

BioNxt Solutions 

$0.36
24
-$0.03-8.34% Thursday 19:45

Statistics

Day High
0.3
Day Low
0.3
52W High
0.77
52W Low
0.26
Volume
225
Avg. Volume
-
Mkt Cap
43.26M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

28NovExpected
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.07
-0.05
-0.03
-0.01
Expected EPS
N/A
Actual EPS
-0.0177

Financials

-19,621.23%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
38,494.56Revenue
-7.55MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BNXTF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap20.57B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with BioNxt Solutions' focus on next-generation sequencing technologies.
Thermo Fisher Scientific
TMO
Mkt Cap195.7B
Thermo Fisher Scientific offers a broad range of biotechnology product development services, including genomics and proteomics, which overlaps with BioNxt Solutions' offerings in life sciences and diagnostics.
Pacific Biosciences of California
PACB
Mkt Cap510.38M
Pacific Biosciences specializes in long-read sequencing technologies, which competes with BioNxt Solutions' efforts in advanced genomic sequencing solutions.
Qiagen NV
QGEN
Mkt Cap8.5B
Qiagen provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the molecular diagnostics and research markets with BioNxt Solutions.
Bio-Rad Laboratories
BIO
Mkt Cap8.07B
Bio-Rad Laboratories offers products and systems used to separate complex chemical and biological materials, directly competing with BioNxt Solutions in the life sciences research and clinical diagnostics markets.
Agenus
AGEN
Mkt Cap183.93M
Agenus is involved in the discovery and development of immunotherapies, which competes with BioNxt Solutions' work in biotechnological solutions for healthcare, particularly in the development of diagnostics and treatments.
Guardant Health
GH
Mkt Cap11.85B
Guardant Health focuses on liquid biopsies and cancer diagnostics, competing with BioNxt Solutions in the development of advanced diagnostics for cancer and other diseases.
Adaptive Biotechnologies
ADPT
Mkt Cap2.23B
Adaptive Biotechnologies is engaged in the immune-driven medicine space, which competes with BioNxt Solutions' focus on innovative healthcare solutions, particularly in diagnostics and research.
CRISPR Therapeutics
CRSP
Mkt Cap5.57B
CRISPR Therapeutics is focused on the development of gene-based medicines, competing with BioNxt Solutions in the area of genetic research and potential therapeutic applications.

About

BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression, anxiety, addiction, and trauma-related stress disorder. The company also develops point-of-care diagnostics comprising rapid diagnostics and biosensor screening tests for early detection and the potential for better treatment outcomes, and improved disease management; and COVID-19 PCR diagnostic kit, peri-implantitis oral biosensor, and H1N1 (swine flu) and H5N1 (avian flu) oral biosensors. In addition, it offers analytical testing and consulting services; and engages in the pathogen and oral health diagnostic and screening test, thin film drug formulation, and psychedelic pharmaceutical production and formulation businesses. The company was formerly known as XPhyto Therapeutics Corp. and changed its name to BioNxt Solutions Inc. in November 2022. BioNxt Solutions Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Hugh A. D. Rogers B.Sc., LL.B
Country
Canada
ISIN
CA0909741062

Listings

STU
DE
BXT.STU
MU
DE
BXT.MU
CN
CA
BNXT.CN
F
DE
BXT.F

0 Comments

Share your thoughts

FAQ

What is BioNxt Solutions stock price today?▼
The current price of BNXTF is $0.36 USD — it has decreased by -8.34% in the past 24 hours. Watch BioNxt Solutions stock price performance more closely on the chart.
What is BioNxt Solutions stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BioNxt Solutions stocks are traded under the ticker BNXTF.
Is BioNxt Solutions stock price growing?▼
BNXTF stock has fallen by -4.7% compared to the previous week, the month change is a -2.99% fall, over the last year BioNxt Solutions has showed a +4.99% increase.
What is BioNxt Solutions market cap?▼
Today BioNxt Solutions has the market capitalization of 43.26M
What were BioNxt Solutions earnings last quarter?▼
BNXTF earnings for the last quarter are -0.02 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BioNxt Solutions revenue for the last year?▼
BioNxt Solutions revenue for the last year amounts to 38,494.56 USD.
What is BioNxt Solutions net income for the last year?▼
BNXTF net income for the last year is -7.55M USD.
In which sector is BioNxt Solutions located?▼
BioNxt Solutions operates in the Health & Wellness sector.
When did BioNxt Solutions complete a stock split?▼
BioNxt Solutions has not had any recent stock splits.
Where is BioNxt Solutions headquartered?▼
BioNxt Solutions is headquartered in Vancouver, Canada.